GSLAX
Price
$15.63
Change
-$0.06 (-0.38%)
Updated
May 23 closing price
Net Assets
418.35M
VIVIX
Price
$65.92
Change
-$0.08 (-0.12%)
Updated
May 23 closing price
Net Assets
183.65B
Interact to see
Advertisement

GSLAX vs VIVIX

Header iconGSLAX vs VIVIX Comparison
Open Charts GSLAX vs VIVIXBanner chart's image
Goldman Sachs Large Cap Value A
Price$15.63
Change-$0.06 (-0.38%)
VolumeN/A
Net Assets418.35M
Vanguard Value Index I
Price$65.92
Change-$0.08 (-0.12%)
VolumeN/A
Net Assets183.65B
GSLAX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSLAX vs. VIVIX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSLAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. GSLAX (418M). VIVIX pays higher dividends than GSLAX: VIVIX (2.35) vs GSLAX (1.10). GSLAX was incepted earlier than VIVIX: GSLAX (25 years) vs VIVIX (27 years). GSLAX (1.25) is less costly to investors than VIVIX (0.04). GSLAX is a more actively managed with annual turnover of: 51.00 vs. VIVIX (9.00). GSLAX has a lower initial minimum investment than VIVIX: GSLAX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 5.52 vs. GSLAX (-3.83). VIVIX return over 5 years is better than : 74.27 vs. GSLAX (32.27).
GSLAXVIVIXGSLAX / VIVIX
Total Expense Ratio1.000.042,500%
Annual Report Gross Expense Ratio1.250.043,125%
Fund Existence25 years27 years-
Gain YTD-1.013-0.139730%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets418M184B0%
Annual Yield % from dividends1.102.3547%
Returns for 1 year-3.835.52-69%
Returns for 3 years5.9820.9029%
Returns for 5 years32.2774.2743%
Returns for 10 years-4.8098.21-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRVI6.290.11
+1.78%
Trevi Therapeutics
ESE178.400.45
+0.25%
ESCO Technologies
SSY0.85N/A
-0.12%
SunLink Health Systems
EQH51.80-0.33
-0.63%
Equitable Holdings
SKLZ6.05-0.49
-7.49%
Skillz